OBJECTIVE -To compare steroids and their associations in men with type 1 diabetes and healthy control subjects.RESEARCH DESIGN AND METHODS -We studied 52 adult men with type 1 diabetes without microvascular complications, compared with 53 control subjects matched for age and BMI. Steroids and their binding globulins were assessed in a single venous blood sample and a 24-h urine sample.RESULTS -In adult men with type 1 diabetes, total testosterone did not differ from healthy control subjects, but sex hormone-binding globulin (SHBG) (42 [14 -83] vs. 26 [9 -117] nmol/l, P Ͻ 0.001), cortisol-binding globulin (CBG; 0.87 Ϯ 0.17 vs. 0.73 Ϯ 0.10 nmol/l, P Ͻ 0.001), and cortisol levels (0.46 Ϯ 0.16 vs. 0.39 Ϯ 0.14 nmol/l, P Ͻ 0.01) were higher. The free testosterone index was lower (60 [17-139] vs. 82 [24 -200], P Ͻ 0.001), and the calculated free testosterone was slightly lower (497 [115] vs. 542 [130], P Ͻ 0.064), but the pituitary-gonadal axis was not obviously affected in type 1 diabetes. The calculated free serum cortisol was not different, and 24-h urinary free cortisol excretion was lower in type 1 diabetes (121 [42-365] vs. 161 nmol/24 h, P Ͻ 0.009). Testosterone was mainly associated with SHBG. Estimated portal insulin was a contributer to SHBG in control subjects but not in type 1 diabetes. Cortisol was associated with CBG. HbA 1c contributed to CBG in men with diabetes but not in control subjects, whereas estimated portal insulin did not contribute.CONCLUSIONS -Adult men with fairly controlled type 1 diabetes without complications who are treated with subcutaneous insulin have a tendency to hypogonadism, as reflected by lower free testosterone levels in the presence of similar total testosterone levels and higher SHBG levels.
Diabetes Care 26:1812-1818, 2003T here are several reports about abnormalities of steroids in type 1 diabetes. Besides the well-known risk factors such as diabetes duration, hyperglycemia, hypertension, and hyperlipidemia (1), steroids may also be involved in the development of micro-and macrovascular complications. However, the data about steroid levels presented in the literature are not unequivocal (2-17). Several factors, such as insulin treatment, insulin resistance, glucose levels, presence of complications such as neuropathy or retinopathy, age, and sex, are likely to be involved in the explanation of the variation of the results between the different publications. In most studies, testosterone levels did not differ between type 1 diabetes and control subjects (2,3,5,6), except in patients with neuropathy (15) or erectile dysfunction (14) and in adolescents (4), who all had lower levels of total testosterone. Because sex hormonebinding globulin (SHBG) levels are often increased, free testosterone levels may be lower in type 1 diabetes (5,11,12,18). Also, for other steroids, differences between type 1 diabetes and control subjects may be present. However, none of these studies described the associations between steroids and their binding globulins in a single homogenous study po...